Crossmark

Successful Treatment with Sirolimus of a Patient with a Novel CARD11 Germline Mutation in B-Cell Expansion with Nuclear Factor Kappa B and T-Cell Anergy: Case Report and Literature Review

Crossref DOI link: https://doi.org/10.1007/s10875-025-01872-4

Published Online: 2025-02-25

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nishinosono, Tsubasa https://orcid.org/0009-0003-0558-1916
Muramatsu, Hideki https://orcid.org/0000-0002-8801-0021
Wakamatsu, Manabu

Yamashita, Daiki

Fukasawa, Tatsuya

Shirakawa, Yuichi

Sajiki, Daichi

Maemura, Ryo

Tsumura, Yusuke

Yamamori, Ayako

Narita, Kotaro

Kataoka, Shinsuke

Narita, Atsushi

Nishio, Nobuhiro

Miyajima, Yuji

Takahashi, Yoshiyuki https://orcid.org/0000-0001-8644-171X
Funding

Funding for this research was provided by:

Japanese Ministry of Health, Labour and Welfare (20FC1053)

Nagoya Pediatric Cancer Fund
License Information

Text and Data Mining valid from 2025-02-25

Version of Record valid from 2025-02-25
More Information

Article History

Received: 24 December 2023

Accepted: 9 February 2025

First Online: 25 February 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Nagoya University Graduate School of Medicine (Date 25/01/2023; Approval number TT23001).

: Written informed consent was obtained from the parents.

: The authors affirm that human research participants provided informed consent for publication of the images in Fig. .

: The authors declare no competing interests.

Document is current

Any future updates will be listed below